Truvada Hub




Andrew Sullivan And Rich Juzwiak Talk The 'Brotherhood of Gay Sex': Audio

Gawker writer Rich Juzwiak recently guested on Andrew Sullivan's podcast and the two took part in a frank conversation about their feelings on gay men and sex. Sullivan describes their talk:

Juzwiak-banner1We actually talk about the sexual adventurism of gay men – a subculture where no women restrain sexual desire – as an often wonderful thing, regardless of the judgment that so many, including gay men, have made about it.

Juzwiak openly expressed his candid opinions:

"I know that there are consequences to being promiscuous, but I could never argue against it. I just really feel like its such a wonderful way to meet people and engender brotherhood, too. That's what I'm really into now. This feeling of brotherhood amongst gay men where I can go home with a guy and we can hang out in bed in the morning for hours naked fooling around talking, fooling around while we're talking. That I just think is just specific to gay sexuality."

Listen to a 2 1/2 minute clip, AFTER THE JUMP...

Sullivan also points out that Juzwiak, who had discontinued taking the drug Truvada earlier this year, published a new piece on Gawker Wednesday wherein he explains why he's not only taking the pill again but encourages "all sexually active gay men who are negative should go on it, at least those who are in the highly populated gray area."

From the Gawker piece:

I try to be as nonjudgmental as possible when it comes to the behavior of other gay men (though I cannot refrain from judging those who judge). We are all in different places in life; we all enjoy different things. That variety is, in fact, what makes gay culture so vibrant. The choices at the disposal of those who are privileged enough to live in areas where gay is OK and where same-sex marriage is legal—these are part what make being gay so wonderful. But if you cannot deal with taking a single pill every day, you need to get a grip and reevaluate your life. After you do that, then just take the fucking pill.

The full podcast episode of the Sullivan/Juzwiak conversation is available (by subscription only) here

Continue reading "Andrew Sullivan And Rich Juzwiak Talk The 'Brotherhood of Gay Sex': Audio" »


'New York Times' Explains Conflicting Truvada Effectiveness Stats

The New York Times has published an insightful, data-driven rundown clarifying the sometimes conflicting information concerning Truvada that’s in circulation.

IPrEx_OLE_logoThe primary point of contention, writes Josh Barro, is linked to Truvada users actually taking the drug consistently, the way it’s prescribed. iPrEx, the first large scale, randomized PrEP trial using human subjects, found that Truvada users were 44% less likely to test HIV positive at the end of the trial compared to participants given a placebo. Participants who didn’t consistently take the drug, however, did not display the same immunity:

Of 48 iPrEx subjects who were assigned to take Truvada and contracted H.I.V. anyway, just four had any detectable level of the drug in their system when they were diagnosed, indicating a 92 percent reduction in risk for people who were actually taking the medicine.

But wait, there’s more: Those four subjects who took Truvada and became infected had its active ingredients in their blood only at levels consistent with taking the drug twice a week. That is, in the study, there were zeroapparent cases of subjects taking their pills daily and contracting H.I.V.

iPrEx’s sample size was relatively small sample size of 2,500 people and the fact that only 18% of participants were shown to have taken the drug daily made it difficult for researchers to claim 100% efficacy.

But by looking at the handful of infections among people taking their pills less than daily, the iPrEx researchers were able to build a statistical model of how the risk of infection declines as the number of pills taken weekly rises. In 2012, they estimated that actually taking Truvada every day produces a 99 percent reduction in the risk of H.I.V. infection, despite not directly observing any such infections.

The general consensus within the HIV/AIDS research community is that Truvada is, in fact, helpful in the prevention of contracting the, but doctors remain wary of putting a precise percentage on current studies.


Read through a an in-depth iPrEx fact sheet AFTER THE JUMP...

Continue reading "'New York Times' Explains Conflicting Truvada Effectiveness Stats" »


'New York' Magazine looks at Prep, Sex and Fear

Nymag

New York Magazine has published a lengthy exploration into the current conversation surrounding Truvada, pre-exposure prophylaxis (PrEP), and the gay male relationship to sex itself.

107091581truvadacropFor some, like Jacobs, the advent of this drug is nothing short of miraculous, freeing bodies and minds. For doctors, public-health officials, and politicians, it is a highly promising tool for stopping the spread of HIV. Other gay men worry that the very existence of such a drug is a kind of betrayal: of those who’ve died in the epidemic; of fealty to the condom, an object alternately evoking fear and resilience, hot sex and safe-sex fatigue; and of a mind-set of sexual prudence that has governed gay-male life since the early ’80s.

Tenofovir and emtricitabine, the two antiretrovirals that make up Truvada, are both featured on the World Health Organization’s List of Essential Medicines, a guide detailing drugs absolutely necessary for a fully functioning healthcare system. Earlier this week the WHO made public its support for the use of Truvada as PrEP, a decision met with equal amounts of support and vitriol. The divide, as Tim Murphy describes it in New York Magazine, is often generational in nature.

The idea of prep can be especially fraught for older gay men, particularly HIV-positive ones. Larry Kramer, now 79, in poor health and HIV-positive since the 1980s, has been the most prominent voice projecting contempt and bafflement: “Anybody who voluntarily takes an antiviral every day has got to have rocks in their heads. There’s something to me cowardly about taking Truvada instead of using a condom. You’re taking a drug that is poison to you, and it has lessened your energy to fight, to get involved, to do anything.”

Reasoning behind arguments against the use of Truvada as PrEP range from claims that the drug encourages high-risk behavior to worries that drug-resistant strains of HIV will flourish should users not take the drug properly. Many of the initial concerns about Truvada’s side effects have been proven false, but only time will provide a more well rounded picture of the drug’s effects on users in the long term.

Watch the New York Times’s Truvada explainer AFTER THE JUMP...

Continue reading "'New York' Magazine looks at Prep, Sex and Fear" »


How The Hobby Lobby Decision Could Undermine The Fight Against HIV/AIDS

The Supreme Court's decision in Burwell v. Hobby Lobby Stores, Inc. could pose a significant threat to the fight for broader access to comprehensive treatment for HIV/AIDS. The ruling, handed down last week, held that closely held, for-profit corporations could be exempt from laws in direct conflict with their religious beliefs.

ImageHobby Lobby took specific issue with four forms of contraception the Affordable Care Act required it to provide its employees through its healthcare. While the bulk of the Hobby Lobby conversation has centered around religious objections to contraceptives, Media Matters points out that similar arguments could be made against Truvada, a drug just as socially polarizing.

A form of pre-exposure prophylaxis, (PrEP) Truvada has proven itself to be an overwhelmingly effective means of blocking HIV infection when taken properly. With a 99% efficacy rate, an endorsement from the CDC, and increasing deployment in public health initiatives, Truvada has the potential to be a key component in halting new HIV infection rates.

As Carlos Maza points out in Media Matters, however, the conversation around Truvada bears a striking resemblance to the debate about birth control. "[T]he Truvada debate recalls the way birth control was viewed in some quarters in the 1960s -- as an accessory to promiscuity."


NY Governor Andrew Cuomo Seeks to End New York's AIDS Epidemic

New York Governor Andrew M. Cuomo announced an ambitious plan to eradicate HIV in New York State by 2020 yesterday in a press release. Cuomo’s “Bending The Curve” initiative seeks to see a fall in new HIV infections to the point where the overall number of HIV infected individuals living in New York State is reduced for the first time. The Governor’s office is defining the end of the HIV epidemic as that point when “the total number of new HIV infections has fallen below the number of HIV-related deaths,” according to the press release.

Cuomobio

"Thirty years ago, New York was the epicenter of the AIDS crisis -- today I am proud to announce that we are in a position to be the first state in the nation committed to ending this epidemic,” said Governor Cuomo. “New York State has reached an important milestone in controlling the AIDS epidemic.”

“Bending The Curve” focuses on three points of action in order to reach its goal: Identifying undiagnosed HIV infected persons, ensuring access to antiretroviral treatment, and providing access to Pre-Exposure Prophylaxis for high-risk, HIV negative populations.

Cuomo’s plan would also streamline the process through which HIV tests can be requested during medical checkups and allow data gathered by the health department to be shared with healthcare providers minimizing the number of patients that go without care.

In addition to providing the necessary medical support to curtail the epidemic, Bending The Curve also seeks to provide critical quality of life support, an often overlooked aspect of HIV treatment. With “[a] 30% cap of the proportion of an HIV patient’s income that can be spent on rent,” the plan aims at eliminating situations in which people are forced to choose between health care and having a place to live.

“The goal is ambitious, but grounded in reality,” said Mark Harrington, executive director of the Treatment Action Group, an AIDS research and policy think tank. “[New York State has seen] an almost 40 percent decrease in new HIV diagnoses in the last decade, with fewer new infections each year, while nationally there has been no decline in the annual number of new HIV infections.

The plan also represents a major financial investment for the State itself. In addition to a projected prevention of 3,400 new infections, New York would also stand to save some $317 million in health care costs.


CDC Endorses Truvada in New Ad HIV Ad Campaign

Screen Shot 2014-05-24 at 5.53.26 PM

The Centers for Disease Control and Prevention (CDC) has unveiled a new ad campaign encouraging gay men to talk about HIV prevention with their partners. In the ads, the CDC endorses preventative medications like Truvada, saying:

Even before the foreplay, something oughta be on your mind. Talking. About testing, your status, and condoms. And new options like medicines that prevent and treat HIV. 

The CDC came out in favour of preventative HIV medications earlier this month, in what was seen as a vital moment in the debate over the "gay pill".

For recent coverage of Truvada on Towleroad, click here, here, and here.

Watch a couple of the ads, AFTER THE JUMP...

Screen Shot 2014-05-24 at 6.10.37 PM

Continue reading "CDC Endorses Truvada in New Ad HIV Ad Campaign" »


Trending



Towleroad - Blogged